Students in leadership positions learn about brain tumors and gain real world experience in running a non-profit business while raising funds for brain tumor research. Beneficiaries of the money we raise are Barrow Neurological Institute, National Brain Tumor Society, Phoenix Childrens Hospital, Steele Childrens Research Center in Tucson, and Translational Genomics Research Institute (TGen). With your help we can make a difference. The intent of our website is to further our objectives of disseminating information about this disease process, stimulating more widespread involvement within our community through donating, volunteering and participating in one or more of our events, and publicizing and promoting this exceptional student-run organization.

"Be the change you wish to see in the world..." Gandhi

Thanks for visiting. Your support is greatly appreciated.

Upcoming Events


Philanthropic "Quotes"

  • “Generosity is the flower of justice.”

  • “It is every man's obligation to put back into the world at least the equivalent of what he takes out of it.”

  • “No person was ever honored for what he received. Honor has been the reward for what he gave.”



Brain Tumor News

  • Researchers at the Perelman School of Medicine at the University of Pennsylvania (Philadelphia, PA) have developed a fluorescence imaging tool that makes tumors glow brightly during surgery. In a new study, the fluorescence method illuminated brain tumors in real time during surgery, helping physicians distinguish between healthy and cancerous tissue.

  • A study identified alterations in a protein known as ATRX in human brain tumors that arise as part of a genetically inherited condition known as neurofibromatosis type 1 (NF1). The disorder, marked initially by benign tumors on nerves, often leads to brain cancer, and although most NF1-related malignancies are nonaggressive, a fraction are "high-grade" and difficult to treat, experts say.

  • Two recently discovered genetic differences between brain cancer cells and normal tissue cells -- an altered gene and a snippet of noncoding genetic material -- could offer clues to tumor behavior and potential new targets for therapy, Johns Hopkins scientists report.

  • Scientists, however, are still seeking more effective medications with fewer side effects. If they succeed in their efforts to better target blood vessels, patients will be able to live with cancer, just as HIV patients now live with the virus.

  • Optune is another option that is now available at the Cancer Center at St. Vincent Anderson Regional Hospital. The Food and Drug Administration-approved device looks like a white cap but is actually four adhesive patches, called transducer arrays, that are placed on the scalp.

blank line

SSBTR in the News

© Copyright 2016